Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Baricitinib is effective and safe for treating severe alopecia areata.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Wigs significantly improve the well-being of people with severe hair loss.

Hair camouflage offers various options for hair loss, helping reduce psychological impact.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Lupus patients' body image issues significantly affect their mental health and need more support.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

PCOS increases sexual pain distress in infertile women.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.